Press release
Neoantigen Targeted Therapies Market Set to Reach $16.01 Billion by 2029 with 36% Yearly Growth
Neoantigen Targeted Therapies Market
The upward trend in cancer occurrences is anticipated to fuel the advancement of the neoantigen targeted therapies market. The term "incidence of cancer" designates the accumulation of novel cancer instances within a specified community over a given timeline. It's fairly common for therapies targeting neoantigens to be utilized in conjunction to treat an array of cancer types. For example, according to the American Cancer Society (ACS), a volunteer health organization based in the US, there were 1.9 million fresh the cancer diagnoses in the United States in 2022, marking a substantial rise compared to preceding years. Similarly in 2022, the US reported approximately 609,360 cancer-related mortalities, underlining the deadly seriousness and influence of this illness on the patients and their close ones. Consequently, the escalating frequency of cancer instances propels the neoantigen targeted therapies market's development.
Get Your Neoantigen Targeted Therapies Market Report Here:
https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report
What Is the projected market size and growth rate for the neoantigen targeted therapies market?
The market for neoantigen targeted therapies has seen an explosive growth in recent times. The market size, currently at $3.4 billion in 2024, is set to increase to $4.72 billion in 2025, with a compound annual growth rate (CAGR) of 38.7%. The expansion during the historic period can be credited to progression in genomic sequencing, the evolution of immunotherapy, advancements in understanding tumor immunology, clinical achievements of checkpoint inhibitors, and the development in molecular profiling.
The market for neoantigen targeted therapies is anticipated to witness tremendous growth over the coming years, rising to a projected value of $16.01 billion by 2029, with a compound annual growth rate (CAGR) of 35.7%. This growth, expected over the forecasted period, can be ascribed to progress in the fields of bioinformatics, expansion of precision medicine, development of neoantigen vaccines, the validation of therapeutic combination strategies, and biomarkers. Key trends for the forecasted period are managing resistance to neoantigens, neoantigen-primed adoptive cell therapies, combination therapies based on neoantigens, real-world data integration, and improved predictive models.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11944&type=smp
What new trends are reshaping the neoantigen targeted therapies market and its opportunities?
Leaders in the neoantigen targeted therapies market, like BioNTech SE, are resorting to strategic collaborations to revolutionise cancer treatments and address the limitations of current immunotherapy for solid tumors. These tactical alliances allow these companies to share expertise and resources for mutual benefits. For example, BioNTech SE, a pioneering biotech firm from Germany, joined forces with the UK Government to enhance personalized mRNA cancer immunotherapies in January 2023. The collective effort aims to administer specified treatments to roughly 10,000 patients by 2030, focusing on key sectors such as cancer immunotherapy development, infectious disease vaccine research, and the establishment of a research and development centre in Cambridge. This venture will capitalize on the UK's robust clinical trial framework and health data resources to boost patient recruitment and find suitable locations for BioNTech's mRNA treatments' trials. The company is preparing to launch its inaugural clinical trials in the UK later this year, targeting cancer vaccines that could merge into conventional treatment procedures if verified to be successful.
What major market segments define the scope and growth of the neoantigen targeted therapies market?
The neoantigen targeted therapies market covered in this report is segmented -
1) By Type: Monotherapy, Combination Therapy
2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
4) By Route Of Administration: Intradermal, Intravenous, Subcutaneous
5) By Application: Medical Research Institution, Hospital, And Clinic, Other Applications
Subsegments:
1) By Monotherapy: Individual Neoantigen-Targeted Treatments
2) By Combination Therapy: Neoantigen-Targeted Therapies Combined With Other Immunotherapies, Neoantigen-Targeted Therapies Combined With Chemotherapy, Neoantigen-Targeted Therapies Combined With Targeted Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11944
Which region dominates the neoantigen targeted therapies market?
North America was the largest region in the neoantigen targeted therapies market in 2024. The regions covered in the neoantigen targeted therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the neoantigen targeted therapies industry growth?
Major companies operating in the neoantigen targeted therapies market include F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Kite Pharma Inc., Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Precision Biologics Inc., Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11944&type=smp
What Is Covered In The Neoantigen Targeted Therapies Global Market Report?
• Market Size Forecast: Examine the neoantigen targeted therapies market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the neoantigen targeted therapies market for a structured understanding.
• Key Players Overview: Analyze major players in the neoantigen targeted therapies market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the neoantigen targeted therapies market.
• Segment Contributions: Evaluate how different segments drive overall growth in the neoantigen targeted therapies market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the neoantigen targeted therapies market.
• Industry Challenges: Identify potential risks and obstacles affecting the neoantigen targeted therapies market.
• Competitive Landscape: Review strategic developments in the neoantigen targeted therapies market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neoantigen Targeted Therapies Market Set to Reach $16.01 Billion by 2029 with 36% Yearly Growth here
News-ID: 3897906 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Target
Enterprise Target Operating Model Toolkit
Today, Capstera.com, a leading force in strategic business architecture solutions, is thrilled to announce the release of its cutting-edge Enterprise Target Operating Model Toolkit. This toolkit serves as the ultimate resource for enterprises aiming to revolutionize their operations from the ground up.
The Enterprise Target Operating Model Toolkit is designed to help organizations effectively align their strategy, people, processes, and technology. Containing a wealth of information, interactive templates, case studies, and…
Target Drones Market - Numerous Advantages Offered By Target Drones Over Unmanne …
Target drone can be defined as an unmanned remote controlled aerial vehicle, mostly utilized in the anti-aircraft crews training. The British DH.82 Queen Bee was one of the earliest drones and was a variant of the Tiger Moth trainer aircraft. Target drones are similar to radio-controlled model aircrafts. More modern drones may use countermeasures, radar, and similar systems to mimic manned aircraft. In the modern advanced drones, large, older missiles…
High Purity Aluminum Target Market
https://www.qandqmarketresearch.com/reports/7273640/high-purity-aluminum-target-market-80
The High Purity Aluminum Target market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for High Purity Aluminum Target.
This report presents the worldwide High Purity Aluminum Target…
Drug Discovery Outsourcing Market : Target Identification, Target Validation, Hi …
Global Drug Discovery Outsourcing Market: Overview
Drug discovery outsourcing involves a process of inventing a new medicine in the field of pharmaceuticals, biotechnology, and pharmacology. Drug discovery outsourcing is a complex, lengthy, and expensive process. Despite advanced technologies, success rate of drug discovery is very low and the time involved is relatively high. The process of drug discovery outsourcing involves target identification, target validation, high-speed screening, and lead optimization.
View Report: https://www.transparencymarketresearch.com/drug-discovery-outsourcing.html
The…
Sputtering Target Material Market Report 2018: Segmentation by Type (Metal Targe …
Global Sputtering Target Material market research report provides company profile for Praxair, Grikin, Plansee, Ningbo Jiangfeng, Honeywell, JX Nippon Mining & Metals Corporation, TOSOH, Sumitomo Chemical, Mitsui Mining & Smelting, ULVAC and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
BPOut stays on target
At the beginning of the year the BPOut announced the growth of the various teams, in Germany as well as internationally, as one of the most essential points of the strategy for 2014.
A short look back at the first quarter confirms that the company stays on target due to several new projects with existing clients in addition to the increase of A350 electrics team. This fact indicates the trust that…
